Tomatsu S, Fukuda S, Sukegawa K, Ikedo Y, Yamada S, Yamada Y, Sasaki T, Okamoto H, Kuwahara T, Yamaguchi S
Department of Pediatrics, Gifu University School of Medicine, Japan.
Am J Hum Genet. 1991 Jan;48(1):89-96.
We identified two different exonic point mutations causing beta-glucuronidase (beta G1) deficiency in two Japanese patients with mucopolysaccharidosis type VII (MPSVII). Enzyme assay of lysates of the lymphocytes and cultured fibroblasts showed little residual activity. The beta G1-specific mRNA levels were normal, as determined by northern blot analysis. Mutated cDNA clones, including the entire coding sequence, were isolated using the polymerase chain reaction (PCR) products derived from beta G1-deficient fibroblasts. Sequence analysis of the full-length mutated cDNAs showed C----T transitions, which resulted in a single Ala619----Val change (case 1, a 24-year-old male) and a Arg382----Cys change (case 2, a 7-year-old female). The former change was revealed by a loss of the cleavage site for the Fnu4HI in the mutated cDNA. On the basis of the loss of Fnu4HI restriction site, the patient (case 1) was a homozygote with this mutation. The mutational change in patient 2 was confirmed by direct sequencing and by demonstrating heterozygosity for the mutation in her parents. The Ala619----Val and Arg382----Cys mutations each disrupt a different domain which is highly conserved among human, rat, and Escherichia coli beta G1s. Each of these two amino acid changes reduced the beta G1 activity of the corresponding mutant beta G1 expressed following transfection of COS cells with expression vectors harboring the mutated cDNAs.
我们在两名日本黏多糖贮积症VII型(MPSVII)患者中鉴定出两种不同的外显子点突变,这些突变导致β-葡萄糖醛酸酶(βG1)缺乏。淋巴细胞和培养的成纤维细胞裂解物的酶活性测定显示几乎没有残余活性。通过Northern印迹分析确定,βG1特异性mRNA水平正常。使用源自βG1缺陷型成纤维细胞的聚合酶链反应(PCR)产物分离出包括完整编码序列的突变cDNA克隆。全长突变cDNA的序列分析显示C→T转换,导致单个Ala619→Val变化(病例1,一名24岁男性)和Arg382→Cys变化(病例2,一名7岁女性)。前一种变化通过突变cDNA中Fnu4HI切割位点的缺失得以揭示。基于Fnu4HI限制性位点的缺失,患者(病例1)是该突变的纯合子。患者2的突变变化通过直接测序以及证明其父母中该突变的杂合性得以证实。Ala619→Val和Arg382→Cys突变各自破坏了一个不同的结构域,该结构域在人、大鼠和大肠杆菌的βG1中高度保守。在用携带突变cDNA的表达载体转染COS细胞后,这两种氨基酸变化中的每一种都降低了相应突变型βG1的βG1活性。